Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERBALIFE LTD. Director's Dealing 2017

Dec 29, 2017

32337_dirs_2017-12-29_3c3511f1-bd75-4be1-8f85-17dc1414d44d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2017-12-27

Reporting Person: Harms Thomas (SVP, China & APAC)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-12-27 Common Stock M 1000 $21.565 Acquired 1000 Direct
2017-12-27 Common Stock D 309 $70.00 Disposed 691 Direct
2017-12-27 Common Stock F 261 $70.00 Disposed 430 Direct
2017-12-27 Common Stock M 15000 $6.82 Acquired 15430 Direct
2017-12-27 Common Stock D 1462 $70.00 Disposed 13968 Direct
2017-12-27 Common Stock F 5436 $70.00 Disposed 8532 Direct
2017-12-29 Common Stock S 8532 $68.49 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-12-27 Stock Appreciation Right $21.565 M 1000 Disposed 2018-02-28 Common Stock (1000) Direct
2017-12-27 Stock Appreciation Right $6.82 M 15000 Disposed 2019-02-27 Common Stock (15000) Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2017.

F2: The reporting person received 430 shares of common stock upon the net exercise of 1,000 stock appreciation rights ("SARs"). The reporting person forfeited 309 shares of common stock underlying such SARs in payment of the exercise price and 261 shares of common stock underlying such SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on December 27, 2017 of $70.00.

F3: The reporting person received 8,102 shares of common stock upon the net exercise of 15,000 SARs. The reporting person forfeited 1,462 shares of common stock underlying such SARs in payment of the exercise price and 5,436 shares of common stock underlying such SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on December 27, 2017 of $70.00.